Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies

Chest

Volumn 112, Issue 3, 1997, Pages 676-692

  Wan, S ^a   Leclerc, J L ^a   Vincent, J L ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Antioxidants; Aprotinin; Cardiac surgery; Complement; Corticosteroids; Cytokine; Endothelin; Endotoxin; Heat shock; Heparin; Inflammatory response; Leukocyte; Ultrafiltration

Indexed keywords

ANTIOXIDANT; APROTININ; CYTOKINE; ENDOTHELIN; ENDOTOXIN; HEAT SHOCK PROTEIN; HEPARIN; NITRIC OXIDE; OXYGEN RADICAL; THROMBOCYTE ACTIVATING FACTOR;

ARACHIDONIC ACID METABOLISM; ARTICLE; CARDIOPULMONARY BYPASS; CELL ADHESION; COMPLEMENT ACTIVATION; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LIVER FUNCTION; PRIORITY JOURNAL; TREATMENT OUTCOME; ULTRAFILTRATION;

EID: 0030818330     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.3.676     Document Type: Article

References (235)

1. Kirklin JK Kirklin JW. Cardiopulmonary bypass for cardiac surgery Sabiston DC Jr Spencer FC Surgery of the chest 5th ed. 1990 WB Saunders Philadelphia 1107 1125
2. Elgebaly SA Houser SL El Kerm AF Evidence of cardiac inflammation after open heart operations Ann Thorac Surg 57 1994 391 396
3. Cremer J Martin M Redl H Systemic inflammatory response syndrome after cardiac operations Ann Thorac Surg 61 1996 1714 1720
4. Utley JR. Pathophysiology of cardiopulmonary bypass: current issues J Card Surg 5 1990 177 189
5. Chenoweth DE Cooper SW Hugli TE Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins N Engl J Med 304 1981 497 503
6. Cavarocchi NC Schaff HV Orszulak TA Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass Surgery 98 1985 525 531
7. Kirklin JK Chenoweth DE Naftel DC Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state Ann Thorac Surg 41 1986 193 199
8. Moore FD Jr Warner KG Assousa S The effects of complement activation during cardiopulmonary bypass: attenuation by hypothermia, heparin, and hemodilution Ann Surg 208 1988 95 103
9. Jansen NJG van Oeveren W Gu YJ Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass Ann Thorac Surg 54 1992 744 748
10. Fosse E Mollnes TE Ingvaldsen B. Complement activation during major operations with or without cardiopulmonary bypass J Thorac Cardiovasc Surg 93 1987 860 866
11. Hammerschmidt DE Stroncek DF Bowers TK Complement activation and neutropenia occurring during cardiopulmonary bypass J Thorac Cardiovasc Surg 81 1981 370 377
12. Cavarocchi NC England MD Schaff HV Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation Circulation 74 suppl 1986 III-130 III-133
13. Kirklin JK Westaby S Blackstone EH Complement and the damaging effects of cardiopulmonary bypass J Thorac Cardiovasc Surg 86 1983 845 857
14. Westfall SH Stephens C Kesler K Complement activation during prolonged extracorporeal membrane oxygenation Surgery 110 1991 887 891
15. Steinberg JB Kapelanski DP Olson JD Cytokine and complement levels in patients undergoing cardiopulmonary bypass J Thorac Cardiovasc Surg 106 1993 1008 1016
16. Tennenberg SD Clardy CW Bailey WW Complement activation and lung permeability during cardiopulmonary bypass Ann Thorac Surg 50 1990 597 601
17. Bando K Pillai R Cameron DE Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass J Thorac Cardiovasc Surg 99 1990 873 877
18. Wakefield TW Kirsh MM Till GO Absence of complement-mediated events after protamine reversal of heparin anticoagulation J Surg Res 51 1991 72 76
19. Seghaye MC Duchateau J Grabitz RG Complement activation during cardiopulmonary bypass in infants and children: relation to postoperative multiple system organ failure J Thorac Cardiovasc Surg 106 1993 978 987
20. Seghaye MC Duchateau J Grabitz RG Complement, leukocytes, and leukocyte elastase in full-term neonates undergoing cardiac operation J Thorac Cardiovasc Surg 108 1994 29 36
21. Dreyer WJ Michael LH Millman EE Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass Cardiovasc Res 29 1995 775 781
22. Dreyer WJ Michael LH Millman EE Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass: evidence for a CD18-dependent mechanism Circulation 92 1995 2276 2283
23. Gu YJ van Oeveren W Boonstra PW Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass Ann Thorac Surg 53 1992 839 843
24. Gillinov AM Bator JM Zehr KJ Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators Ann Thorac Surg 56 1993 847 853
25. Rinder CS Bonan JL Rinder HM Cardiopulmonary bypass induces leukocyte adhesion Blood 79 1992 1201 1205
26. Gillinov AM Redmond JM Zehr KJ Inhibition of neutrophil adhesion during cardiopulmonary bypass Ann Thorac Surg 57 1994 126 133
27. Gillinov AM Redmond JM Winkelstein JA Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog Ann Thorac Surg 57 1994 345 352
28. Youker KA Hawkins HK Kukielka GL Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart Circulation 89 1994 2736 2746
29. Horgan MJ Wright SD Malik AB. Antibody against leukocyte integrin (CD18) prevents reperfusion-induced lung vascular injury Am J Physiol 259 1990 L315 19
30. Byrne JG Smith WJ Murphy MP Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion J Thorac Cardiovasc Surg 104 1992 1589 1596
31. Boldt J Osmer C Schindler E Circulating adhesion molecules in cardiac operations: influence of high-dose aprotinin Ann Thorac Surg 59 1995 100 105
32. McCord JM. Oxygen-derived free radicals in postischemic tissue injury N Engl J Med 312 1985 159 163
33. Prasad K Kalra J Chaudhary AK Polymorphonuclear leukocyte activation and cardiac function at organ and cellular level Am Heart J 119 1990 538 550
34. Ferreira R Llesuy S Milei J Assessment of myocardial oxidative stress in patients after myocardial revascularization Am Heart J 115 1988 307 312
35. Weisel RD Mickle DAG Finkle CD Myocardial free-radical injury after cardioplegia Circulation 80 suppl 1989 III-14 III-18
36. Davies SW Underwood SM Wickens DG Systemic pattern of free radical generation during coronary bypass surgery Br Heart J 64 1990 236 240
37. Prasad K Kalra J Bharadwaj B Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery Am Heart J 123 1992 37 45
38. Davies SW Duffy JP Wickens DG Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass J Thorac Cardiovasc Surg 105 1993 979 987
39. Toivonen HJ Ahotupa M. Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting J Thorac Cardiovasc Surg 108 1994 140 147
40. Pesonen EJ Korpela R Peltola K Regional generation of free oxygen radicals during cardiopulmonary bypass in children J Thorac Cardiovasc Surg 110 1995 768 773
41. Seccombe JF Pearson PJ Schaff HV. Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries J Thorac Cardiovasc Surg 107 1994 505 509
42. Pearson PJ Lin PJ Schaff HV. Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery: a possible cause of vasospasm after cardiopulmonary bypass J Thorac Cardiovasc Surg 103 1992 1147 1154
43. Haniuda M Dresler CM Mizuta T Free radical-mediated vascular injury in lungs preserved at moderate hypothermia Ann Thorac Surg 60 1995 1376 1381
44. Menasche P Peynet J Larivière J Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions? Circulation 90 pt 2 1994 II-275 II-279
45. Menasche P Peynet J Haeffner-Cavaillon N Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass Circulation 92 suppl 2 1995 II-334 II-340
46. Le Deist F Menasche P Kucharski C Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion: a clinical study. Circulation 92 suppl 2 1995 II-354 II-358
47. Downing SW Edmunds LH Jr Release of vasoactive substances during cardiopulmonary bypass Ann Thorac Surg 54 1992 1236 1243
48. Singh HP Coleman ET Hargrove M Prostacyclin and thromboxane levels in pleural space fluid during cardiopulmonary bypass Ann Thorac Surg 59 1995 647 650
49. Hashimoto K Miyamoto H Suzuki K Evidence of organ damage after cardiopulmonary bypass: the role of elastase and vasoactive mediators J Thorac Cardiovasc Surg 104 1992 666 673
50. 2: an initiating mediator of reperfusion injury? J Thorac Cardiovasc Surg 105 1993 689 693
51. 2 mediates pulmonary hypertension after cardiopulmonary bypass in the rabbit J Thorac Cardiovasc Surg 106 1993 959 967
52. 2 receptor-specific antagonism in hypothermic cardiopulmonary bypass Ann Thorac Surg 57 1994 999 1006
53. Smith WJ Murphy MP Appleyard RF Prevention of complement-induced pulmonary hypertension and improvement of right ventricular function by selective thromboxane receptor antagonism J Thorac Cardiovasc Surg 107 1994 800 806
54. Friedman M Wang SY Sellke FW Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition Ann Thorac Surg 59 1995 598 603
55. Faichney A Davidson KG Wheatley DJ Prostacyclin in cardiopulmonary bypass operations J Thorac Cardiovasc Surg 84 1982 601 608
56. 2 release in ischaemic arrest in isolated working rat heart Int J Cardiol 55 1996 265 270
57. 1 infusion for right ventricular failure after cardiac transplantation J Thorac Cardiovasc Surg 103 1992 33 39
58. Gadaleta D Fahey AL Verma M Neutrophil leukotriene generation increases after cardiopulmonary bypass J Thorac Cardiovasc Surg 108 1994 642 647
59. Utoh J Yamamoto T Kambara T Perioperative alteration of neutrophil functions after open heart and other major surgeries J Cardiovasc Surg 30 1989 692 695
60. Gadaleta D Davis JM. Pulmonary failure and the production of leukotrienes J Am Coll Surg 178 1994 309 319
61. Andersen LW Baek L Degn H Presence of circulating endotoxins during cardiac operations J Thorac Cardiovasc Surg 93 1987 115 119
62. Rocke DA Gaffin SL Wells MT Endotoxemia associated with cardiopulmonary bypass J Thorac Cardiovasc Surg 93 1987 832 837
63. Kharazmi A Andersen LW Baek L Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass J Thorac Cardiovasc Surg 98 1989 381 385
64. Nilsson L Kulander L Nyström SO Endotoxins in cardiopulmonary bypass J Thorac Cardiovasc Surg 100 1990 777 780
65. Baue AE. The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients Ann Thorac Surg 55 1993 822 839
66. Ohri SK Bjarnason I Pathi V Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability Ann Thorac Surg 55 1993 1080 1086
67. Andersen LW Landow L Baek L Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-α concentrations in patients undergoing cardiopulmonary bypass Crit Care Med 21 1993 210 217
68. Sinclair DG Haslam PL Quinlan GJ The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability Chest 108 1995 718 724
69. Riddington DW Venkatesh B Boivin CM Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass JAMA 275 1996 1007 1012
70. Tao W Zwischenberger JB Nguyen TT Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand J Thorac Cardiovasc Surg 110 1995 819 828
71. Jansen PGM te Velthuis H Oudemans-van Straaten HM Perfusion-related factors of endotoxin release during cardiopulmonary bypass Eur J Cardiothorac Surg 8 1994 125 129
72. te Velthuis H Jansen PGM Oudemans-van Straaten HM Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor J Thorac Cardiovasc Surg 110 1995 1663 1669
73. Oudemans-van Straaten HM Jansen PGM te Velthuis H Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia Intensive Care Med 22 1996 294 300
74. Watarida S Mori A Onoe M A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels J Thorac Cardiovasc Surg 108 1994 620 625
75. Taggart DP Sundaram S McCartney C Endotoxemia, complement, and white blood cell activation in cardiac surgery: a randomized trial of laxatives and pulsatile perfusion Ann Thorac Surg 57 1994 376 382
76. Wan S LeClerc JL Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation Ann Thorac Surg 63 1997 269 276
77. Wan S Marchant A DeSmet JM Human cytokine responses to cardiac transplantation and coronary artery bypass grafting J Thorac Cardiovasc Surg 111 1996 469 477
78. Ohkawa F Ikeda U Kanbe T Effects of inflammatory cytokines on vascular tone Cardiovasc Res 30 1995 711 715
79. Menasche P Haydar S Peynet J A potential mechanism of vasodilation after warm heart surgery: the temperature-dependent release of cytokines J Thorac Cardiovasc Surg 107 1994 293 299
80. Deng MC Dasch B Erren M Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting Ann Thorac Surg 62 1996 184 190
81. Hennein HA Ebba H Rodriguez JL Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization J Thorac Cardiovasc Surg 108 1994 626 635
82. Preiser JC Schmartz D Van der Linden P Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog Cytokine 3 1991 1 4
83. Partrick DA Moore FA Moore EE The inflammatory profile of interleukin-6, interleukin-8, and soluble intercellular adhesion molecule-1 in postinjury multiple organ failure Am J Surg 172 1996 425 431
84. Eppinger MJ Ward PA Boiling SF Regulatory effects of interleukin-10 on lung ischemia-reperfusion injury J Thorac Cardiovasc Surg 112 1996 1301 1306
85. Wan S DeSmet JM Barvais L Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass J Thorac Cardiovasc Surg 112 1996 806 811
86. Wan S LeClerc JL Schmartz D Hepatic release of interleukin-10 during cardiopulmonary bypass in steroidpretreated patients Am Heart J 133 1997 335 339
87. Ko W Hawes AS Lazenby WD Myocardial reperfusion injury: platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion J Thorac Cardiovasc Surg 102 1991 297 308
88. Kubes P Ibbotson G Russell J Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence Am J Physiol 259 1990 G300 05
89. Raschke P Becker BF. Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischaemia Cardiovasc Res 29 1995 569 576
90. Siren AL Feuerstein G. Effects of platelet activating factor and BN52021 on cardiac functions and regional blood flow in conscious rats Am J Physiol 257 1989 H25 32
91. Sawa Y Schaper J Roth M Platelet-activating factor plays an important role in reperfusion injury in myocardium: efficacy of platelet-activating factor receptor antagonist (CV3988) as compared with leukocyte-depleted reperfusion J Thorac Cardiovasc Surg 108 1994 953 959
92. Zehr KJ Poston RS Lee PC Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass Ann Thorac Surg 59 1995 328 335
93. Mehta JL. Endothelium, coronary vasodilation, and organic nitrates Am Heart J 129 1995 382 391
94. Rodeberg DA Chaet MS Bass RC Nitric oxide: an overview Am J Surg 170 1995 292 303
95. Ruvolo G Greco E Speziale G Nitric oxide formation during cardiopulmonary bypass Ann Thorac Surg 57 1994 1055 1056
96. Li JM Hajarizadeh H La Rosa CA Heparin and protamine stimulate the production of nitric oxide J Cardiovasc Surg 37 1996 445 452
97. Tsujino M Hirata Y Imai T Induction of nitric oxide synthase gene by interleukin-lp in cultured rat cardiocytes Circulation 90 1994 375 383
98. Ungureanu-Longrois D Balligand JL Simmons WW Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists Circ Res 77 1995 494 502
99. Shindo T Ikeda U Ohkawa F Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines Cardiovasc Res 29 1995 813 819
100. 2+-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass Thorax 50 1995 403 404
101. Hill GE Snider S Galbraith TA Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass Am J Respir Crit Care Med 152 1995 1791 1795
102. Evora PRB Pearson PJ Schaff HV. Impaired endothelium-dependent relaxation after coronary reperfusion injury: evidence for G-protein dysfunction Ann Thorac Surg 57 1994 1550 1556
103. Lin PJ Chang CH Lee YS Acute endothelial reperfusion injury after coronary artery bypass grafting Ann Thorac Surg 58 1994 782 788
104. Lefer DJ Nakanishi K Johnston WE Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs Circulation 88 pt l 1993 2337 2350
105. Ma XL Weyrich AS Lefer DJ Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium Circ Res 72 1993 403 412
106. Hiramatsu T Forbess JM Miura T Effects of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia: evidence for an important role of endothelial production of nitric oxide J Thorac Cardiovasc Surg 109 1995 81 87
107. Engelman DT Watanabe M Maulik N L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/reperfusion Ann Thorac Surg 60 1995 1275 1281
108. Vinten-Johansen J Zhao ZQ Sato H. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy Ann Thorac Surg 60 1995 852 857
109. Villarreal D Grisham MB Granger DN. Nitric oxide donors improve gut function after prolonged hypothermic ischemia Transplantation 59 1995 685 689
110. Giaid A Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl J Med 333 1995 214 221
111. Adatia I Lillehei C Arnold JH Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation Ann Thorac Surg 57 1994 1311 1318
112. Van Camp JR Yian C Lupinetti FM. Regulation of pulmonary vascular resistance by endogenous and exogenous nitric oxide Ann Thorac Surg 58 1994 1025 1030
113. Miller OI Celermajer DS Deanfield JE Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease J Thorac Cardiovasc Surg 108 1994 487 494
114. Tonz M von Segesser LK Schilling J Treatment of acute pulmonary hypertension with inhaled nitric oxide Ann Thorac Surg 58 1994 1031 1035
115. Michael JR Markewitz BA. Endothelins and the lung Am J Respir Crit Care Med 154 1996 555 581
116. Chang H Wu GJ Wang SM Plasma endothelin levels and surgically correctable pulmonary hypertension Ann Thorac Surg 55 1993 450 458
117. Zhu ZG Wang MS Jiang ZB The dynamic change of plasma endothelin-1 during the perioperative period in patients with rheumatic valvular disease and secondary pulmonary hypertension J Thorac Cardiovasc Surg 108 1994 960 968
118. Ishikawa S Miyauchi T Sakai S Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair J Thorac Cardiovasc Surg 110 1995 271 273
119. Matheis G Haak T Beyersdorf F Circulating endothelin in patients undergoing coronary bypass grafting Eur J Cardiothorac Surg 9 1995 269 274
120. Hasdai D Erez E Gil-Ad I Is the heart a source for elevated circulating endothelin levels during aorta-coronary artery bypass grafting surgery in human beings? J Thorac Cardiovasc Surg 112 1996 531 536
121. te Velthuis H Jansen PGM Oudemans-van Straaten HM Circulating endothelin in cardiac operations: influence of blood pressure and endotoxin Ann Thorac Surg 61 1996 904 908
122. Dupuis J Stewart DJ Cernacek P Human pulmonary circulation is an important site for both clearance and production of endothelin-1 Circulation 94 1996 1578 1584
123. McGowan FX Jr Davis PJ Siewers RD Coronary vasoconstriction mediated by endothelin-1 in neonates: reversal by nitroglycerin J Thorac Cardiovasc Surg 109 1995 88 98
124. Hiramatsu T Forbess JM Miura T Effects of endothelin-1 and L-arginine after cold ischemia in lamb hearts Ann Thorac Surg 61 1996 36 41
125. 2 increases the vasoconstrictor effect of endothelin-1 in postischemic reperfused rat hearts Circulation 94 1996 742 747
126. Berkenboom G Giot C Unger P Plasma endothelin and early coronary endothelial dysfunction in recipients of a cardiac transplant Am Heart J 129 1995 1178 1184
127. Schersten H Hedner T McGregor CGA Increased levels of endothelin-1 in bronchoalveolar lavage fluid of patients with lung allografts J Thorac Cardiovasc Surg 111 1996 253 258
128. Aharinejad S Schraufnagel DE Miksovsky A Endothelin-1 focally constricts pulmonary veins in rats J Thorac Cardiovasc Surg 110 1995 148 156
129. Replogle RL Gazzaniga AB Gross RE. Use of corticosteroids during cardiopulmonary bypass: possible lysosome stabilization Circulation 33 suppl I 1966 I 86-91
130. Dietzman RH Ersek RA Lillehei CW Low output syndrome: recognition and treatment J Thorac Cardiovasc Surg 57 1969 138 150
131. Dietzman RH Lunseth JB Goott B The use of methylprednisolone during cardiopulmonary bypass: a review of 427 cases J Thorac Cardiovasc Surg 69 1975 870 873
132. Niazi Z Flodin P Joyce L Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgeiy Chest 76 1979 262 268
133. Engelman RM Prasad MR Rousou JA Steroidinduced myocardial preservation with decreased cell membrane microviscosity Circulation 80 suppl III 1989 III-36 III-43
134. Goldman RA Schaff HV Flaherty JT Failure of methylprednisolone to protect myocardial function or prevent myocardial edema following ischemic cardiac arrest J Surg Res 24 1978 477 487
135. Morton JR Hiebert CA Lutes CA Effect of methylprednisolone on myocardial preservation during coronary artery surgery Am J Surg 131 1976 419 422
136. Codd JE Wiens RD Barner HB Steroids and myocardial preservation J Thorac Cardiovasc Surg 74 1977 418 422
137. Tennenberg SD Bailey WW Cotta LA The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass Surgery 100 1986 134 141
138. Andersen LW Baek L Thomsen BS Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery J Cardiothorac Anesth 3 1989 544 549
139. Jansen NJG van Oeveren W.V.D Broek L Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass J Thorac Cardiovasc Surg 102 1991 515 525
140. Jansen NJG van Oeveren W van Vliet M The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass Eur J Cardiothorac Surg 5 1991 211 217
141. Tabardel Y Duchateau J Schmartz D Corticosteroids increase blood interleukin 10 levels during cardiopulmonary bypass in men Surgery 119 1996 76 80
142. Teoh KHT Bradley CA Gauldie J Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery Circulation 92 suppl II 1995 II-347 II-353
143. Engelman RM Rousou JA Flack JE III Influence of steroids on complement and cytokine generation after cardiopulmonary bypass Ann Thorac Surg 60 1995 801 804
144. Kawamura T Inada K Okada H Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery Can J Anaesth 42 1995 399 403
145. Jorens PG de Jongh R de Backer W Interleukin-8 production in patients undergoing cardiopulmonary bypass: the influence of pretreatment with methylprednisolone Am Rev Respir Dis 148 1993 890 895
146. Wan S DeSmet JM Antoine M Steroid administration in heart and heart-lung transplantation: is the timing adequate? Ann Thorac Surg 61 1996 674 678
147. Cronstein BN Kimmel SC Levin RI A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoids receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1 Proc Natl Acad Sci USA 89 1992 9991 9995
148. Engelman RM Rousou JA Flack JE III Fast-track recovery of the coronary bypass patient Ann Thorac Surg 58 1994 1742 1746
149. Westaby S. Aprotinin in perspective Ann Thorac Surg 55 1993 1033 1041
150. Gurevitch J Barak J Hochhauser E Aprotinin improves myocardial recovery after ischemia and reperfusion: effects of the drug on isolated rat hearts J Thorac Cardiovasc Surg 108 1994 109 118
151. Bukhari EA Krukenkamp IB Burns PG Does aprotinin increase the myocardial damage in the setting of ischemia and preconditioning? Ann Thorac Surg 60 1995 307 310
152. Wendel HP Heller W Michel J Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage J Thorac Cardiovasc Surg 109 1995 1164 1172
153. Hill GE Alonso A Spurzem JR Aprotinin and methylprednisolone equally blunt cardiopulmonary bypassinduced inflammation in humans J Thorac Cardiovasc Surg 110 1995 1658 1662
154. Seghaye MC Duchateau J Grabitz RG Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children Ann Thorac Surg 61 1996 1205 1211
155. van Oeveren W Harder MP Roozendaal KJ Aprotinin protects platelets against the initial effect of cardiopulmonary bypass J Thorac Cardiovasc Surg 99 1990 788 797
156. Wachtfogel YT Kucich U Hack CE Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracoiporeal perfusion J Thorac Cardiovasc Surg 106 1993 1 10
157. Shinfeld A Zippel D Lavee J Aprotinin improves hemostasis after cardiopulmonary bypass better than singledonor platelet concentrate Ann Thorac Surg 59 1995 872 876
158. Primack C Walenga JM Koza MJ Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations Ann Thorac Surg 61 1996 1188 1193
159. Jansen PGM Baufreton C Le Besnerais P Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting Ann Thorac Surg 61 1996 1363 1366
160. Prendergast TW Furukawa S Beyer AJ III Defining the role of aprotinin in heart transplantation Ann Thorac Surg 62 1996 670 674
161. Julia PL Buckberg GD Acar C Studies of controlled reperfusion after ischemia: XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage—importance of endogenous oxygen free radical scavengers in red blood cells J Thorac Cardiovasc Surg 101 1991 303 313
162. Pyles LA Fortney JE Kudlak JJ Plasma antioxidant depletion after cardiopulmonary bypass in operations for congenital heart disease J Thorac Cardiovasc Surg 110 1995 165 171
163. Sun SC Appleyard R Mesetti P Improved recovery of heart transplants by combined use of oxygen-derived free radical scavengers and energy enhancement J Thorac Cardiovasc Surg 104 1992 830 837
164. Yau TM Weisel RD Mickle DAG Vitamin E for coronary bypass operations: a prospective, double-blind, randomized trial J Thorac Cardiovasc Surg 108 1994 302 310
165. Ballmer PE Reinhart WH Jordan P Depletion of plasma vitamin C but not of vitamin E in response to cardiac operations J Thorac Cardiovasc Surg 108 1994 311 320
166. Sisto T Paajanen H Metsa-Ketela T Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting Ann Thorac Surg 59 1995 1519 1523
167. Drossos G Lazou A Panagopoulos P Deferoxamine cardioplegia reduces superoxide radical production in human myocardium Ann Thorac Surg 59 1995 169 172
168. 10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect Surgery 120 1996 189 196
169. 10 J Thorac Cardiovasc Surg 108 1994 126 133
170. Gott VL Whiffen JD Dutton RC. Heparin bonding on colloidal graphite surfaces Science 142 1963 1297 1298
171. von Segesser LK Turina M. Cardiopulmonary bypass without systemic heparinization: performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators J Thorac Cardiovasc Surg 98 1989 386 396
172. Dowling RD Brown ME Whittington RO Jr Clinical cardiopulmonary bypass without systemic anticoagulation Ann Thorac Surg 56 1993 1176 1178
173. von Segesser LK Weiss BM Garcia E Clinical application of heparin-coated perfusion equipment with special emphasis on patients refusing homologous transfusions Perfusion 6 1991 227 233
174. von Segesser LK Weiss BM Garcia E Reduction and elimination of systemic heparinization during cardiopulmonary bypass J Thorac Cardiovasc Surg 103 1992 790 799
175. Mollnes TE Videm V Götze O Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin Ann Thorac Surg 52 1991 92 97
176. Videm V Svennevig JL Fosse E Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations J Thorac Cardiovasc Surg 103 1992 806 813
177. Jones DR Hill RC Vasilakis A Safe use of heparin-coated bypass circuits incorporating a pump-oxygenator Ann Thorac Surg 57 1994 815 819
178. von Segesser LK Weiss BM Pasic M Risk and benefit of low systemic heparinization during open heart operations Ann Thorac Surg 58 1994 391 398
179. Pekna M Hagman L Haldén E Complement activation during cardiopulmonary bypass: effects of immobilized heparin Ann Thorac Surg 58 1994 421 424
180. Fosse E Moen O Johnson E Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass Ann Thorac Surg 58 1994 472 477
181. Ovrum E Mollnes TE Fosse E High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes Ann Thorac Surg 60 1995 1755 1761
182. Borowiec J Thelin S Bagge L Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass: a clinical study J Thorac Cardiovasc Surg 104 1992 642 647
183. Ovrum E Brosstad F Åm Holen E Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass Circulation 92 1995 2579 2584
184. Ovrum E Am Holen E Tangen G Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects Ann Thorac Surg 60 1995 365 371
185. Aldea GS Doursounian M O'Gara P Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study Ann Thorac Surg 62 1996 410 418
186. El Habbal MH Smith L Elliott MJ Effect of heparin anticoagulation on neutrophil adhesion molecules and release of IL8: C3 is not essential Cardiovasc Res 30 1995 676 681
187. Korn RL Fisher CA Livingston ER The effects of Carmeda bioactive surface on human blood components during simulated extracorporeal circulation J Thorac Cardiovasc Surg 111 1996 1073 1084
188. Plötz FB van Oeveren W Hultquist KA A heparin-coated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit Artif Organs 16 1992 366 370
189. te Velthuis H Jansen PGM Hack CE Specific complement inhibition with heparin-coated extracorporeal circuits Ann Thorac Surg 61 1996 1153 1157
190. Hatori N Yoshizu H Haga Y Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass Artif Organs 18 1994 904 910
191. Gu YJ van Oeveren W Akkerman C Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass Ann Thorac Surg 55 1993 917 922
192. Weerwind PW Maessen JG van Tits LJH Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass J Thorac Cardiovasc Surg 110 1995 1633 1641
193. Steinberg BM Grossi EA Schwarz DS Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass Ann Thorac Surg 60 1995 525 529
194. Redmond JM Gillinov AM Stuart RS Heparin-coated bypass circuits reduce pulmonary injury Ann Thorac Surg 56 1993 474 479
195. Ranucci M Cirri S Conti D Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction Ann Thorac Surg 61 1996 76 81
196. Pradhan MJ Fleming JS Nkere UU Clinical experience with heparin-coated cardiopulmonary bypass circuits Perfusion 6 1991 235 242
197. Shigemitsu O Hadama T Takasaki H Biocompatibility of a heparin-bonded membrane oxygenator (Carmeda Maxima) during the first 90 minutes of cardiopulmonary bypass: clinical comparison with the conventional system Artif Organs 18 1994 936 941
198. Boonstra PW Gu YJ Akkerman C Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass J Thorac Cardiovasc Surg 107 1994 289 292
199. O'Donnell AF McGovern EM Carson K (1) Is oxygen consumption or lactate production altered by heparin-coated circuits during bypass? (2) Do heparin-coated bypass circuits improve haemodynamic performance following bypass? [abstracts] Br J Surg 82 suppl 1 1995 21
200. Jansen PGM te Velthuis H Huybregts RAJM Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits J Thorac Cardiovasc Surg 110 1995 829 834
201. Muehrcke DD McCarthy PM Kottke-Marchant K Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial J Thorac Cardiovasc Surg 112 1996 472 483
202. Moen O Fosse E Brockmeier V Disparity in blood activation by two different heparin-coated bypass systems Ann Thorac Surg 60 1995 1317 1323
203. Ovrum E Mollnes TE Fosse E Complement and granulocyte activation in two different types of heparinized extracorporeal circuits J Thorac Cardiovasc Surg 110 1995 1623 1632
204. Weissmann G Smolen JE Korchak HM. Release of inflammatory mediators from stimulated neutrophils N Engl J Med 303 1980 27 34
205. Sawa Y Nakano S Shimazaki Y Myocardial protective effect and its mechanism of leukocyte-depleted reperfusion in neonatal rabbit hearts Ann Thorac Surg 58 1994 1386 1391
206. Wilson IC Gardner TJ DiNatale JM Temporary leukocyte depletion reduces ventricular dysfunction during prolonged postischemic reperfusion J Thorac Cardiovasc Surg 106 1993 805 810
207. Lazar HL Zhang X Hamasaki T Role of leukocyte depletion during cardiopulmonary bypass and cardioplegic arrest Ann Thorac Surg 60 1995 1745 1748
208. Wilson IC DiNatale JM Gillinov AM Leukocyte depletion in a neonatal model of cardiac surgery Ann Thorac Surg 55 1993 12 19
209. Pillai R Bando K Schueler S Leukocyte depletion results in excellent heart-lung function after 12 hours of storage Ann Thorac Surg 50 1990 211 214
210. Steimle CN Guynn TP Morganroth ML Neutrophils are not necessary for ischemia-reperfusion lung injury Ann Thorac Surg 53 1992 64 73
211. Eppinger MJ Jones ML Deeb GM Pattern of injury and the role of neutrophils in reperfusion injury of rat lung J Surg Res 58 1995 713 718
212. Kofsky ER Julia PL Buckberg GD Studies of controlled reperfusion after ischemia: XXII. Reperfusate composition: effects of leukocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion J Thorac Cardiovasc Surg 101 1991 350 359
213. Coleman SM Demastrie L. Leukocyte depletion reduces postoperative oxygen requirements Ann Thorac Surg 58 1994 1567 1568
214. Englander R Cardarelli MG. Efficacy of leukocyte filters in the bypass circuit for infants undergoing cardiac operations Ann Thorac Surg 60 1995 S533 35
215. Mihaljevic T Tönz M von Segesser LK The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: a clinical study J Thorac Cardiovasc Surg 109 1995 1138 1145
216. Sawa Y Matsuda H Shimazaki Y Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency artery bypass grafting J Thorac Cardiovasc Surg 108 1994 1125 1131
217. Morioka K Muraoka R Chiba Y Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass J Thorac Cardiovasc Surg 111 1996 45 54
218. Gu YJ de Vries AJ Boonstra PW Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery J Thorac Cardiovasc Surg 112 1996 450 494
219. Naik SK Knight A Elliott M. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery Circulation 84 suppl III 1991 III-422 III-431
220. Journois D Pouard P Greeley WJ Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery: effects on hemostasis, cytokines, and complement components Anesthesiology 81 1994 1181 1189
221. Journois D Israel-Biet D Pouard P High-volume, zero-balanced hemofiltration to reduced delayed inflammatory response to cardiopulmonary bypass in children Anesthesiology 85 1996 965 976
222. Millar AB Armstrong L van der Linden J Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass Ann Thorac Surg 56 1993 1499 1502
223. Wang MJ Chiu IS Hsu CM Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations Ann Thorac Surg 61 1996 651 666
224. Saatvedt K Lindberg H Geiran OR Ultrafiltration after cardiopulmonary bypass in children: effects on hemodynamics, cytokines and complement Cardiovasc Res 31 1996 596 602
225. Yellon DM Alkhulaifi AM Pugsley WB. Preconditioning the human myocardium Lancet 342 1993 276 277
226. Perrault LP Menasche P Bel A Ischemic preconditioning in cardiac surgery: a word of caution J Thorac Cardiovasc Surg 112 1996 1378 1386
227. Burns PG Krukenkamp IB Caldarone CA Does cardiopulmonary bypass alone elicit myoprotective preconditioning? Circulation 92 suppl II 1995 II-447 II-451
228. Menasche P Kevelaitis E Mouas C Preconditioning with potassium channel openers: a new concept for enhancing cardioplegic protection? J Thorac Cardiovasc Surg 110 1995 1606 1614
229. Currie RW Karmazyn M Kloc M Heat-shock response is associated with enhanced postischemic ventricular recovery Circ Res 63 1988 543 549
230. Liu X Engelman RM Moraru II Heat shock: a new approach for myocardial preservation in cardiac surgery Circulation 86 suppl II 1992 II-358 II-363
231. Maulik N Engelman RM Wei Z Interleukin-la preconditioning reduces myocardial ischemia reperfusion injury Circulation 88 pt 2 1993 387 394
232. Maulik N Engelman RM Wei Z Drug-induced heat-shock preconditioning improves postischemic ventricular recovery after cardiopulmonary bypass Circulation 92 suppl II 1995 II-381 II-388
233. Robinson BL Morita T Toft DO Accelerated recovery of postischemic stunned myocardium after induced expression of myocardial heat-shock protein (HSP70) J Thorac Cardiovasc Surg 109 1995 753 764
234. Gorman RC Ziats NP Rao AK Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass J Thorac Cardiovasc Surg 111 1996 1 12
235. Videm V Mollnes TE Garred P Biocompatibility of extracorporeal circulation: in vitro comparison of heparin-coated and uncoated oxygenator circuits J Thorac Cardiovasc Surg 101 1991 654 660